Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yuko Mizunaga"'
Autor:
Yuko Mizunaga, Shuji Terai M.D., Ph.D., Naoki Yamamoto, Koichi Uchida, Takahiro Yamasaki, Hiroshi Nishina, Yusuke Fujita, Koh Shinoda, Yoshihiko Hamamoto, Isao Sakaida
Publikováno v:
Cell Transplantation, Vol 21 (2012)
We previously described the effectiveness of autologous bone marrow cell infusion (ABM i ) therapy for patients with liver cirrhosis (LC). We analyzed chronological changes in 19 serum cytokines as well as levels of specific cytokines in patients aft
Externí odkaz:
https://doaj.org/article/d4d90f3bf7fd47a485721e667316e617
Autor:
Yuko Mizunaga, Koh Shinoda, Naoki Yamamoto, Tomoaki Murata, Yoshio Marumoto, Koji Aoyama, Yohei Urata, Isao Sakaida, Shuji Terai, Tsuyoshi Ishikawa, Hiroshi Nishina
Publikováno v:
Cell and Tissue Research. 327:463-470
We previously reported that fibroblast growth factor 2 (FGF2) facilitated the differentiation of transplanted bone marrow cells (BMCs) into hepatocytes. Our earlier study also demonstrated that administration of FGF2 in combination with bone marrow t
Autor:
Koichi Fujisawa, Yasuho Taura, Isao Sakaida, Ishikawa T, Tokiwa Yamasaki, Takuya Iwamoto, Kouichi Uchida, Isao Hidaka, Yohei Urata, Fujii Y, Marumoto M, Yoshio Marumoto, K Okita, Haruko Tanimoto, Naoki Yamamoto, G. R. Burganova, Kenji Tani, Takashi Oono, Shuji Terai, Taro Takami, T. Matsuda, Fernando Quintanilha L, Hiroshi Nishina, Yuko Mizunaga, Issei Saeki
Publikováno v:
SCOPUS19373368-2014-20-3-SID84900012743
In 2003, we started autologous bone marrow cell infusion (ABMi) therapy for treating liver cirrhosis. ABMi therapy uses 400 mL of autologous bone marrow obtained under general anesthesia and infused mononuclear cells from the peripheral vein. The cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dea013d46723e59796fdb1c814f43a2
https://openrepository.ru/article?id=676178
https://openrepository.ru/article?id=676178
Autor:
Naoki Yamamoto, Yuko Mizunaga, Yusuke Fujita, Isao Sakaida, Koh Shinoda, Takahiro Yamasaki, Shuji Terai, Yoshihiko Hamamoto, Koichi Uchida, Hiroshi Nishina
Publikováno v:
Cell Transplantation, Vol 21 (2012)
We previously described the effectiveness of autologous bone marrow cell infusion (ABM i) therapy for patients with liver cirrhosis (LC). We analyzed chronological changes in 19 serum cytokines as well as levels of specific cytokines in patients afte
Autor:
Toshihiko Matsumoto, Koichi Fujisawa, Masaki Maeda, Masako Tsuchiya, Yuichiro Yokoyama, Yohei Urata, Isao Sakaida, Isao Hidaka, Takahiro Yamasaki, Kaoru Omori, Takuya Iwamoto, Makoto Segawa, Koichi Uchida, Shuji Terai, Tsuyoshi Ishikawa, Haruko Tanimoto, Kiwamu Okita, Yoshio Marumoto, Taro Takami, Takuro Hisanaga, Naoki Yamamoto, Koji Aoyama, Yuko Mizunaga, Junichi Zaitsu
Publikováno v:
Journal of gastroenterology. 47(5)
Liver cirrhosis patients generally progress to liver failure. To cure this progressive disease, we developed a novel cell therapy using bone marrow cells; autologous bone marrow cell infusion (ABMi) therapy. We previously described the possible actio
Autor:
Yuko Mizunaga, Takuya Iwamoto, Isao Sakaida, Koichi Uchida, Kaoru Omori, Shuji Terai, Yasuhiko Fujii, Naoki Yamamoto, Hiroshi Nishina, Takahiro Yamasaki
Publikováno v:
Journal of gastroenterology. 47(3)
In 2003, we initiated a clinical trial to examine autologous bone marrow cell infusion (ABMi) therapy for cirrhotic patients and reported the clinical effect of the therapy. To analyze how splenectomy may potentiate the effects of bone marrow cell in
Autor:
Takeshi, Iida, Yuko, Mizunaga, Tadashi, Okazawa, Masako, Tsuchiya, Yoshito, Inamoto, Seiji, Kaino, Noriyoshi, Kusano, Miyuki, Kaino, Fumie, Kurokawa, Tadahiko, Itoh
Publikováno v:
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology. 104(12)
A 74-year-old woman was admitted to our hospital to treat her hepatocellular carcinoma (stage IVB) with multiple lung metastases. She was treated with 3 times of hepatic arterial infusion of cisplatin powder (IA-call). After the treatment, liver mass